Veracity Capital LLC Eli Lilly & CO Transaction History

Veracity Capital LLC

$261 Million
Q3 2024

A detailed history of Veracity Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Veracity Capital LLC holds 3,252 shares of LLY stock, worth $2.59 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

3,252

Previous 3,159 2.94%

Holding current value

$2.59 Million

Previous $2.86 Million 0.73%

% of portfolio

1.1%

Previous 1.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $71,809 - $89,281	93 Added 2.94%	3,252 $2.88 Million
Q2 2024 Jul 22, 2024	BUY	$724.87 - $909.04 $7,248 - $9,090	10 Added 0.32%	3,159 $2.86 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $27,833 - $37,237	-47 Reduced 1.47%	3,149 $2.45 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $37,813 - $44,577	72 Added 2.3%	3,196 $1.86 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $147,798 - $203,761	340 Added 12.21%	3,124 $1.68 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $132,579 - $177,274	378 Added 15.71%	2,784 $1.31 Million
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $6,523 - $7,661	21 Added 0.88%	2,406 $826,000
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $6,109 - $7,118	19 Added 0.8%	2,385 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $7,708 - $8,784	-26 Reduced 1.09%	2,366 $765,000
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $27,594 - $32,399	-99 Reduced 3.97%	2,392 $776,000
Q1 2022 Apr 18, 2022	BUY	$234.69 - $291.66 $6,336 - $7,874	27 Added 1.1%	2,491 $713,000
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $1,798 - $2,232	-8 Reduced 0.32%	2,464 $681,000
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $6,648 - $8,181	30 Added 1.23%	2,472 $571,000
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $12,457 - $16,114	-69 Reduced 2.75%	2,442 $561,000
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $8,544 - $11,061	52 Added 2.11%	2,511 $469,000
Q4 2020 Jan 25, 2021	BUY	$130.46 - $172.63 $13,176 - $17,435	101 Added 4.28%	2,459 $415,000
Q3 2020 Oct 21, 2020	BUY	$146.22 - $169.13 $10,674 - $12,346	73 Added 3.19%	2,358 $349,000
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $314,993 - $379,091	-2,309 Reduced 50.26%	2,285 $375,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $30,000 - $37,132	-252 Reduced 5.2%	4,594 $637,000
Q4 2019 May 07, 2020	BUY	$106.92 - $132.43 $518,134 - $641,755	4,846 New	4,846 $637,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.

Account

Veracity Capital LLC Eli Lilly & CO Transaction History